Form 4: Omada Health Director Acquires 657 RSUs

Jonathan D. Root, a Director at Omada Health, Inc., acquired 657 restricted stock units as part of his compensation.

Summary

• Jonathan D. Root, a Director of Omada Health, Inc., acquired 657 restricted stock units (RSUs) on October 5, 2025.
• These RSUs were granted pursuant to the Issuer's Non-Employee Director Compensation Program in lieu of retainer fees.
• Each RSU represents the right to receive one share of Omada Health Common Stock.
• Following this transaction, Mr. Root directly beneficially owns 10,630 shares of Common Stock.
• He also indirectly beneficially owns 4,571,769 shares through U.S. Venture Partners X, L.P. and 146,257 shares through USVP X Affiliates, L.P., where he is a managing member of the general partner, Presidio Management Group X, L.L.C.

Sentiment

Score: 7

Explanation: The filing indicates a routine, positive event of director compensation through equity, aligning interests. No negative implications are present.

Positives

• Director Jonathan D. Root received 657 restricted stock units (RSUs) as part of his compensation, aligning his interests with shareholders.
• The grant of RSUs is part of the company's Non-Employee Director Compensation Program, indicating a structured approach to executive incentives.

Risks

• Jonathan D. Root disclaims beneficial ownership of shares held by USVP X Funds, except to the extent of any pecuniary interest, which clarifies his direct exposure to those specific holdings.

Future Outlook

The grant of restricted stock units to a non-employee director suggests a continued commitment to aligning director incentives with long-term shareholder value through equity-based compensation programs.

Industry Context

Equity grants to non-employee directors are a standard practice across many industries, particularly in technology and growth-oriented companies, to attract and retain experienced board members and align their interests with company performance.

Comparison to Industry Standards

• The practice of compensating non-employee directors with restricted stock units (RSUs) in lieu of cash retainer fees is a common and widely accepted corporate governance practice, comparable to compensation structures seen in companies like Teladoc Health, Livongo Health (prior to acquisition), and other digital health or SaaS firms, which aim to foster long-term commitment and shareholder alignment.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of director interests with shareholder value through equity compensation.
• Directors: Compensation received in the form of equity, linking their financial outcomes to the company's stock performance.

Next Steps

• The RSUs will vest according to the terms of the Issuer's Non-Employee Director Compensation Program, leading to the issuance of common stock.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a non-employee director as part of their compensation. While it indicates alignment of interests, it does not present new material information that would fundamentally alter the investment thesis for Omada Health, warranting a 'hold' recommendation based solely on this filing.

Keywords

Omada Health, OMDA, Jonathan D. Root, Form 4, SEC Filing, Restricted Stock Units, RSUs, Director Compensation, Insider Transaction, Equity Grant